What are critical considerations on drug-device integrated development and how to choose the right regulatory and clinical strategy?
How to better adapt smart manufacturing in pharma and boost the opportunities offered by emerging technologies?
What actions medical device manufacturers could take to strengthen the implementation strategy for EU MDR and IVDR?